NHS eRS Changes Explained: What’s Actually Changing in 2026 (and What Isn’t)
April 27, 2026
.svg)
August 27, 2026
The NHS elective waiting list sits at over 7 million. June 2026 was the busiest month on record for A&E. The three busiest months in NHS history have all been in 2026. The numbers keep moving in the wrong direction, and the standard response of more beds, more theatre slots, more staff, only goes so far.
The part that gets less attention is what happens before a patient reaches the operating table. The referral pathway is where a large proportion of the backlog is actually being created.
When a GP refers a patient to secondary care, the expectation is that someone who needs specialist treatment gets it. But the referral pathway is doing a lot more work than that. It's also carrying patients who could have been safely managed in primary care with the right specialist input, patients whose referrals are incomplete and need chasing, and patients sitting in outpatient clinics that exist primarily to decide whether they need surgery at all and some are on the wrong pathway entirely.
Every one of those adds to the list. And the list keeps growing partly because the referral pathway keeps feeding it with cases it was never designed to filter.
The NHS has recognised this. The push toward Advice and Refer, getting specialist input before a referral is made, is a direct attempt to address it. If a GP and a specialist can have a quick conversation before a patient is added to a waiting list, a proportion of those patients never need to be referred at all.
The principle of Advice and Refer works. The tool that’s expected to manage it won’t.
When Specialist Advice takes over 10 minutes, additional information is frequently sought from referrers and less than 50% of patients are being managed away from Acute Hospitals, this approach cannot be more efficient than an appointment first approach.
When you consider that work plans need to allow more time for digital triage and likely less time for appointments the problem magnifies.
These are pathway problems, not clinical ones, and they have pathway solutions.
Read more: Advice & Refer Platforms: A Guide for UK Clinicians
The evidence from services that have reduced their contribution to the elective backlog point to the same things:
In dermatology, structured digital triage, where images and clinical context are shared with a specialist before any referral is made, has led to up to 70% of cases being resolved without an outpatient appointment. Consultants manage the case in a couple of minutes and patients and referrers get an answer fast. The result? The waiting list doesn't grow with cases it doesn't need to carry.
One ICB recently reported that in 12 months 30,000 cases ended up not being sent because the Cinapsis pathways guided the referrer to manage the patient without needing support from Specialist services.
Elective recovery conversations tend to focus on output: how many patients are being treated, how quickly, at what cost. The referral pathway is an input. Getting it right doesn't just help individual patients, it changes the composition of the waiting list itself.
Services that have invested in smarter referral pathways haven't just cleared backlogs faster. They've reduced the rate at which new ones form.
For ICBs and trusts looking at where to focus elective recovery effort, the referral pathway is worth more attention than it typically gets. The waiting list is a symptom. The referral pathway is closer to the cause.
Want to understand how smarter referral pathways are working in practice? Read our urgent care case study or get in touch with the Cinapsis team.
.svg)
